首页> 外文期刊>药学学报(英文版) >Discovery of highly selective and orally available benzimidazole-based phosphodiesterase 10 inhibitors with improved solubility and pharmacokinetic properties for treatment of pulmonary arterial hypertension
【24h】

Discovery of highly selective and orally available benzimidazole-based phosphodiesterase 10 inhibitors with improved solubility and pharmacokinetic properties for treatment of pulmonary arterial hypertension

机译:发现高选择性和口服的苯并咪唑基磷酸二酯酶10抑制剂,具有改进的溶解性和药代动力学性能,用于治疗肺动脉高血压

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《药学学报(英文版)》 |2020年第12期|2339-2347|共9页
  • 作者单位

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

    School of Pharmaceutical Sciences Sun Yat-sen University Guangzhou 510006 China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号